Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Buy
9,650
+996
+12% +$22K 0.01% 1052
2026
Q1
$127K Buy
8,654
+4,369
+102% +$64.1K 0.01% 1484
2025
Q4
$54.2K Sell
4,285
-831
-16% -$12.3K ﹤0.01% 2028
2025
Q3
$78.7K Sell
5,116
-19
-0.4% -$306 ﹤0.01% 1682
2025
Q2
$80.7K Buy
5,135
+3,198
+165% +$48.5K 0.01% 1599
2025
Q1
$37K Sell
1,937
-86
-4% -$1.88K ﹤0.01% 2006
2024
Q4
$48.2K Buy
2,023
+239
+13% +$6.67K ﹤0.01% 1684
2024
Q3
$50K Buy
1,784
+510
+40% +$14.4K 0.01% 1498
2024
Q2
$33.3K Buy
1,274
+328
+35% +$6.82K ﹤0.01% 1491
2024
Q1
$20.7K Sell
946
-232
-20% -$4.97K ﹤0.01% 1628
2023
Q4
$24.5K Buy
+1,178
New +$23.7K 0.01% 1358

Other funds holding RXO

GAMMA Investing's RXO Position: Q2 2026 in Review

GAMMA Investing increased its RXO (RXO) stake by 12% in Q2 2026, buying an estimated $22K and bringing the position to 9,650 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #1052.

GAMMA Investing first reported a position in RXO in Q4 2023 and has held it in 11 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • GAMMA Investing held 9,650 shares of RXO worth $266K as of Q2 2026.
  • GAMMA Investing bought 996 RXO shares in Q2 2026, an estimated $22K.
  • RXO made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1052 holding.
  • GAMMA Investing first reported a position in RXO in Q4 2023 and has held it in 11 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.